Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives
2022 · European Journal of Medicinal Chemistry · 50 citations
https://doi.org/10.1016/j.ejmech.2022.114176
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
618
Citations
12
h-index
14
i10-index
Changyu Ren is an academic researcher from Chengdu Fifth People's Hospital. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Protein Degradation and Inhibitors & Histone Deacetylase Inhibitors Research. The author has an h-index of 12, co-authored 23 publications.
Click to start Chat